Which von Willebrand disease (vWD) types are treated with desmopressin (DDAVP)?

Updated: Dec 30, 2019
  • Author: Eleanor S Pollak, MD; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print

DDAVP is the treatment of choice for individuals with vWD type 1. Responses to DDAVP are variable in patients with type 2 disease. Individuals with vWD type 3 have a virtually complete deficiency of vWF; therefore, because DDAVP acts by releasing stored vWF, the drug has no effect in type 3 disease.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!